Clinical Trial Update: Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible [Phase 2]

View source ↗

Summary

Phase 2 pilot trial of pazopanib in patients with relapsed/refractory AML or newly diagnosed where intensive treatment isn’t possible completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: University Hospital Muenster | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED